Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : The Pharmaceutical Journal, 31 January 2015, Vol 294, No 7847

Sort by: Newest first Oldest first A-Z Z-A

  • Patients taking medicines affected by new drug driving laws will need timely and accurate advice from pharmacists

    Drug driving law must not be a burden for patients

    29 JAN 2015 15:32

    Patients taking medicines affected by new drug driving laws will need timely and accurate advice from pharmacists.

  • No-blame culture should be fostered in pharmacy Subscription

    29 JAN 2015 15:32

    Even though the requirement to name a community pharmacy in patient safety reports has been postponed, the sector must do more to improve the reporting of dispensing errors.

  • People who consume up to seven drinks per week in early-to-middle age have a significantly lower risk of developing heart failure, recent study finds

    Moderate drinking linked to lower risk of heart failure Subscription

    29 JAN 2015 15:12

    In a study of 15,000 adults, those who consumed up to seven drinks per week in early-to-middle age had a significantly lower risk of developing heart failure compared with their teetotal counterparts.

  • Survey shows that in patients who have taken aspirin as primary prevention, treatment was inappropriate in nearly 11.6% of cases

    Aspirin inappropriately used for CVD prevention in just over 10% of cases Subscription

    29 JAN 2015 15:12
    Comments (1)

    A survey of nearly 70,000 patients taking aspirin for primary prevention has found that, for the overall cohort, treatment was inappropriate in nearly 11.6% of cases.

  • According to suggestions from the latest Nuffield Trust report "Now more than ever" community pharmacists must shift their core activities away from dispensing function towards a more clinical role

    Dispensing: it’s time to let it go Subscription

    29 JAN 2015 15:11 By Darrin Baines
    Comments (7)

    If the aspirations of pharmacy fulfilling a clinical role integral to public healthcare is ever to be realised, community pharmacists must shift their focus away from dispensing and towards providing health services.

  • A recent study shows how glucocorticoids tightly control the inflammatory response. US researchers infected mice with a lethal strain of Haemophilis influenzae (pictured).

    Study shows how glucocorticoids tightly control the inflammatory response Subscription

    29 JAN 2015 11:34

    IRAK-M, a key negative regulator of inflammatory pathways, may represent a new therapeutic target to suppress bacteria-induced inflammation, say researchers.

  • Alex MacKinnon, director, Royal Pharmaceutical Society (RPS) for Scotland

    RPS Scotland targets greater clinical role for pharmacy in 2015 Subscription

    29 JAN 2015 11:33 By Stephen Robinson

    Business plan for 2015 sets out Royal Pharmaceutical Society Scotland’s ambitions for the Prescription for Excellence programme

  • Study on adverse cognitive outcomes attributable to statins questions the validity of the US Food and Drug Administration's (FDA) warning on the effects of statins. In the image, building 66 of the FDA

    Study questions FDA warning over adverse cognitive effects of statins Subscription

    29 JAN 2015 10:19

    In 25 placebo-controlled trials involving nearly 47,000 patients, adverse cognitive outcomes attributable to statins were rarely reported, researchers found.

  • Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages

    Drug shortages: it’s time for Europe to act Subscription

    29 JAN 2015 10:18 By Ingrid Torjesen
    Comments (1)

    Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.

  • Tribute to Eugene Thomas Fitzpatrick Ball Subscription

    27 JAN 2015 16:40 By Patrick Ball

    My father passed away on 5 January 2014, aged 93. Eugene (Gene) registered in 1944 and worked for the whole of his working life for the Boots Company. A dedicated pharmacist, he nevertheless also brought to work his outside interests in photography and high-fidelity sound. This caused some consternation among his seniors when his Weoley Castle, Birmingham, branch outsold many larger branches in cameras and audio. Nevertheless, his prime focus was always the wellbeing of the patient.

  • Attendees at the Royal Pharmaceutical Society (RPS) conference in 2014. Employers urged to add Royal Pharmaceutical Society (RPS) membership to pharmacy job descriptions.

    Employers urged to add RPS membership to pharmacy job descriptions Subscription

    27 JAN 2015 15:37

    Group of London pharmacy employers says joining professional membership bodies can boost career development and improve patient care

  • Eugene Thomas Fitzpatrick Ball dies Subscription

    27 JAN 2015 15:03 By Patrick Ball

    On 5 January 2015, Eugene Thomas Fitzpatrick Ball, aged 93, of 1 Oak Close, Harborne, Birmingham B17 9AW. Mr Ball registered with the Society in 1944. He left the Society in 2010.

  • Peter Richard West dies Subscription

    27 JAN 2015 14:31

    On 21 January 2015, Peter Richard West MRPharmS, aged 57, of 48 Oaklands, Guilden Sutton, Chester CH3 7HE. Mr West registered with the Society in 1979.

  • Pamela Robertson Hall dies Subscription

    27 JAN 2015 14:28

    On 23 January, Pamela Robertson Hall MRPharmS, aged 71, of High Widden, Pitmore Lane, Sway, Lymington, Hampshire SO41 6BW. Mrs Hall registered with the Society in 1965.

  • UK deaths from coronary heart disease (CHD) have declined by 60% since the 1970s

    Analysis questions value of primary prevention medication for reducing CHD deaths Subscription

    27 JAN 2015 12:13

    Population-wide approaches to risk-factor control have had a far greater impact on the reduction of deaths from coronary heart disease than use of primary prevention medication.

  • Recent small studies have raised concerns that use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients undergoing surgery may be associated with anastomotic leak at the surgical junction

    Use of NSAIDs associated with surgery complication Subscription

    27 JAN 2015 9:41
    Comments (1)

    Use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients undergoing surgery may be associated with anastomotic leak at the surgical junction, research confirms.

  • Maurice Slinger dies Subscription

    27 JAN 2015 9:33

    On 27 November 2014, Maurice Slinger MRPharmS, aged 89, of Heathfield, Hobcote Lane, Oakworth, Keighley BD22 0RW. Mr Slinger registered with the Society in 1948.

  • What is causing the delay to decriminalising dispensing errors? Subscription

    26 JAN 2015 18:03 By Joy Wingfield

    Well hooray and alleluia! A ray of common sense pierces the clouds of officialdom. Now community pharmacists will not have to “dob themselves in” to the authorities until legal defences are put in place to counter the strict liability offence that arises when a dispensing error is made. I would like to claim my blog (The Pharmaceutical ...

  • The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body could offer invaluable guidance for drug developers

    Human Protein Atlas reveals drug targets Subscription

    26 JAN 2015 11:09 By Mark Peplow

    The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body and could offer invaluable guidance for drug developers. 

  • A tattoo-based iontophoresis-sensor platform holds considerable promise for efficient diabetes management, say researchers

    Tattoo-based sensor could eliminate invasive glucose monitoring Subscription

    23 JAN 2015 15:36

    A tattoo-based iontophoresis-sensor platform holds considerable promise for efficient diabetes management, say researchers.

  • The European Medicines Agency (EMA) approved AbbVie’s Viekirax and Exviera, licensed together for the treatment of hepatitis C genotype 1

    EU approval of AbbVie’s hepatitis C combination therapies challenges Gilead’s Harvoni Subscription

    23 JAN 2015 14:05 By Janna Lawrence

    A highly effective therapy for patients with hepatitis C is being launched by AbbVie in the EU over the next couple of months in direct competition with another treatment made by Gilead that was approved in 2014 and is now being rolled out. 

  • Pharmacist trainees who completed their training in the community sector are more likely to be dissatisfied with the experience according to a recent survey conducted on behalf on the General Pharmaceutical Council (GPhC)

    Pre-reg pharmacists dissatisfied with their training more likely to have trained in community sector Subscription

    23 JAN 2015 12:46 By Debbie Andalo
    Comments (1)

    Pharmacist trainees who completed their training in the community sector are more likely to be dissatisfied with the experience, while a higher proportion of dissatisfied students trained in London.

  • Gillian Judith Day dies Subscription

    23 JAN 2015 12:32

    On 5 December 2014, Gillian Judith Day MRPharmS, aged 75, of 2 Boston Close, Bramhall, Stockport, Cheshire SK7 2BP. Mrs Day registered with the Society in 1961.

  • Pharmacists are set to work alongside emergency department staff at up to 36 A&E units across England from March 2015 in a significant expansion of an NHS pilot programme

    Pharmacists set to be drafted into dozens of A&E departments in England Subscription

    23 JAN 2015 12:29 By Stephen Robinson
    Comments (4)

    Large expansion of NHS pilot project will see many more pharmacists working in emergency departments.

  • Tribute for Robert Blyth Subscription

    23 JAN 2015 11:59 By Bruce Rhodes

    So Robert Blyth, the one-time editor of The Pharmaceutical Journal, is no longer with us. I can’t imagine Robert “shuffling off this mortal coil”, because he was not that sort of man.

  • Saturday 28 February/Sunday 1 March: Pre-registration mock exam and revision course Subscription

    23 JAN 2015 11:47

    Royal Pharmaceutical Society (RPS) event, ‘Pre-registration mock exam and revision course’. Holiday Inn Bloomsbury, Coram Street, London WC1N 1HT. Weekend event, 9am–5.30pm on Saturday and Sunday. Book via the RPS website.

  • Wednesday 22 April: Joint QP symposium Subscription

    23 JAN 2015 11:46

    Joint Royal Pharmaceutical Society (RPS) and Royal Society of Chemistry and Society of Biology event, ‘14th Joint Qualified Person (QP) Symposium’. Holiday Inn Bloomsbury, Coram St, London WC1N 1HT. Event 9.30am–4pm. Book via the RPS website.

  • Wednesday 18 February: RPS Faculty webinar Subscription

    23 JAN 2015 11:31

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: is it for me? What is involved? How long does it take to build my portfolio? Online 7–8pm. Register and access the webinar via the RPS website.

  • Tuesday 10 February: RPS Faculty webinar Subscription

    23 JAN 2015 11:30

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: is it for me? What is involved? How long does it take to build my portfolio? Online 1–2pm. Register and access the webinar via the RPS website.

  • Amira Guirguis, a researcher, is designing a model to improve on-site identification of new psychoactive substances of misuse

    Discovering how to identify new psychoactive substances through PhD research Subscription

    23 JAN 2015 10:07 By Amira Guirguis

    Researcher Amira Guirguis is designing a model to improve on-site identification of new psychoactive substances of misuse. She explains why the work is vital to reduce unnecessary hospital admissions and prevent avoidable deaths.

  • No more pro-pharmacy rhetoric: we need action Subscription

    22 JAN 2015 15:27 By Graham Phillips

    GP surgeries and accident and emergency departments are under siege. Barely a day goes past without the issue being highlighted in the nation’s media and discussed by politicians of all persuasions. Everyone, it seems, agrees that pharmacy is a significant part of the answer and the Royal Pharmaceutical Society and other pharmacy bodies have done a great job of

  • Male patients with type 2 diabetes, who have a degree and earn more than US$60,000 a here are more likely to take their prescribed medicines, recent survey shows

    Study sheds light on factors affecting adherence in patients with diabetes Subscription

    22 JAN 2015 15:09 By Debbie Andalo
    Comments (1)

    Patients with type 2 diabetes are more likely to take their medicines as prescribed if they are male, have a degree and earn more than US$60,000 a year.

  • Harm from low molecular weight heparins Subscription

    22 JAN 2015 15:04

    NHS England has issued a patient safety alert to remind practitioners of the harm caused from using low molecular weight heparins when they are contraindicated. More information is available from the NHS England website.

  • Administration of ciclosporin not recommended with Olysio Subscription

    22 JAN 2015 15:02

    The summary of product characteristics for Olysio (simeprevir; Janssen-Cilag) now states that co-administration with ciclosporin is not recommended because this leads to significantly higher exposure of simeprevir. 

  • 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol

    Almost 42% of US drinkers report taking drugs that interact with alcohol Subscription

    22 JAN 2015 14:56

    Some 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol, according to research published in Alcoholism: Clinical and Experimental Research.

  • Draft recommendations for sun exposure Subscription

    22 JAN 2015 14:52

    The National Institute for Health and Care Excellence (NICE) is consulting on draft recommendations to help people strike the right balance when it comes to being out in the sun. Communicating the benefits and risks of sunlight exposure to the general public is contentious because exposing the skin to too much time in the sun is a risk for skin cancer but too little can lead to vitamin D deficiency. The draft recommendations aim to give people a better understanding of the various ...

  • Antifungal agents interactions app and databases Subscription

    22 JAN 2015 14:40

    The Fungal Infection Trust and the National Aspergillosis Centre have developed a freely available online resource and app for iPhone, iPad and Android devices, which displays potential interactions between antifungal agents and other medicines. The collaboration supported the development of two databases, one for patients and

  • Polypharmacy guide Subscription

    22 JAN 2015 14:39

    NHS East and South East England specialist pharmacy services have published a guide to managing polypharmacy for all healthcare professionals. The document supports clinical staff, including all sectors of the pharmacy profession, in acute, mental health primary and community care, and commissioners, in helping patients to get the best health outcome through evidence-based medication review.

  • Protamine sulphate injection discontinued Subscription

    22 JAN 2015 14:33

    Protamine sulphate injection 50mg/5ml has been discontinued by RPH Pharmaceuticals. More information is available on 01283 495280.

  • Further delays to Amdipharm Mercury stock Subscription

    22 JAN 2015 14:31

    There have been further delays to the supply of some Amdipharm Mercury products. Trifluoperazine tablets 1mg x 112 are now expected to be back in stock by February 2015. Gentamicin eye/ear drops 0.3% w/v x 10ml and guanethidine monosulphate ampoules 10mg/ml x 5 are expected to be back in stock by March 2015. Gentamicin and hydrocortisone acetate ear drops 0.3%/1% w/v x 10ml are now expected to be back in stock by April 2015. Diloxanide tablets 500mg x 30 are expected by October 2015. 

  • Erythroped Forte, glycopyrronium, Hytrin and methotrexate out of stock Subscription

    22 JAN 2015 14:29

    The following products are currently out of stock from Amdipharm Mercury: Erythroped Forte SF (erythromycin ethyl succinate) suspension 500mg/5ml, 140ml x 20, glycopyrronium bromide solution for injection 200µg/ml x 10 ampoules; glycopyrronium bromide solution for injection 600µg/3ml x 3 ampoules; and glycopyrronium 0.5mg/ml and neostigmine 2.5mg/ml injection; hytrin tablets 2mg and 5mg, both x 28; and methotrexate tablets 2.5mg x 24. All products are due back in stock by February 2015 ...

  • Chloroquine sulphate syrup has been discontinued Subscription

    22 JAN 2015 14:27

    Chloroquine sulphate syrup (Nivaquine; Sanofi) has been discontinued and will no longer be marketed in the UK. The expiry date for the last batch supplied is March 2015. Other chloroquine phosphate syrup preparations are not currently available in the UK. As an alternative, chloroquine phosphate is available in a tablet form used alone or in combination with proguanil. 

  • Women taking valproate should be told about risks of developmental disorders in offspring Subscription

    21 JAN 2015 17:50

    Women taking valproate should be told about the risks of developmental disorders in children exposed to the drug during pregnancy, says the UK medicines regulator.

  • The cost of vaccines recommended by the World Health Organization (WHO) for developing countries has increased by 68%, warns Médecins sans Frontières (MSF)

    Cost of vaccines becoming unaffordable in developing countries, charity warns Subscription

    21 JAN 2015 12:34 By Debbie Andalo

    The cost of vaccines recommended by the World Health Organization has gone up 68-fold over the past 13 years, according to international aid charity Médecins sans Frontières.

  • Audit highlights problem of patients taking NSAIDs without gastroprotection Subscription

    21 JAN 2015 9:54

    Many patients taking non-steroidal anti-inflammatory drugs are not co-prescribed gastroprotective agents, an audit of community pharmacies in England has found.

  • The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies.

    Cancer Drugs Fund has undermined NICE, its chair admits Subscription

    20 JAN 2015 17:10 By Janna Lawrence

    The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.

  • Light micrograph of liver sarcoidosis, a non-malignant immunological disorder characterised by non-caseating (non-necrotising) granulomas.

    Identifying and managing sarcoidosis Subscription

    20 JAN 2015 By Lloyd Mayers, Sarah Mulholland

    Sarcoidosis is a complex immunological disorder that requires careful management and vigilant monitoring.

  • David Taylor, pharmacist, academic and one of the top clinical leaders in Britain in 2014

    Answering clinical conundrums as a psychiatry research leader Subscription

    19 JAN 2015 16:35 By Stephen Robinson

    Pharmacist and academic David Taylor, lead author of ‘The Maudsley prescribing guidelines’, was named as one of the top clinical leaders in Britain in 2014. He discusses why he believes pharmacy’s future lies in clinical aspects of care and research.

  • Cost of cancer drugs Subscription

    19 JAN 2015 16:06

    Elizabeth Sukkar, deputy news editor of The Pharmaceutical Journal, talked to BBC Radio Leicester about the cost of cancer drugs and cost of developing new medicines.

  • Assisted dying laws Subscription

    19 JAN 2015 13:04

    14 January 2015: The Times and The Scotsman reported that Holyrood was considering new laws to allow assisted dying in Scotland. They focused on the fact that “doctors in Scotland have demanded a ‘conscience clause’ be inserted into new laws on assisted suicide”.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.